Results 41 to 50 of about 623,470 (191)

Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman's Disease)

open access: yes, 1993
A novel renal complication was reported in a patient with angiofollicular lymph node hyperplasia (Castleman's Disease), who developed acute renal failure due to membranoproliferative glomerulonephritis.
Chan, TM, Wong, KL, Cheng, IKP, Chan, KW
core   +1 more source

Deciphering the full spectrum of Castleman diseases based on a cohort of 700 patients in a western country

open access: yesBritish Journal of Haematology, Volume 208, Issue 6, Page 2036-2046, June 2026.
The spectrum of Castleman diseases has expanded over the past three decades. The phenotype of the diseases varies not only among the three major types but also according to the patient ancestry. Summary Under the Castleman disease (CD) eponym, three distinct diseases sharing common pathological features have been described over time.
Eric Oksenhendler   +4 more
wiley   +1 more source

Rituximab Monotherapy in the Management of a Rare Case of an HIV Associated Lymphoproliferative Disorder

open access: yesCase Reports in Oncological Medicine, Volume 2017, Issue 1, 2017., 2017
Background. Castleman’s disease (CD), also known as angiofollicular node hyperplasia, is a rare heterogenous lymphoproliferative disorder. This disease exists as two distinct entities: a localized or unicentric CD (UCD) which has a more benign clinical course and multicentric CD (MCD) which is a systemic disease and carries a worse prognosis.
Jason Hew   +3 more
wiley   +1 more source

Cutaneous Disorders Associated with Castleman’s Disease

open access: yesActa Dermato-Venereologica, 2019
Castleman’s disease is a rare disease of the lymph nodes and related tissues, presenting as angiofollicular or giant lymph node hyperplasia. Although various skin manifestations have been reported to occur in Castleman’s disease, a comprehensive study of
Hyo Jung Kim   +10 more
doaj   +1 more source

Castleman Disease in Tunisia: A Multicenter Clinical, Prognostic, and Therapeutic Study

open access: yesAdvances in Hematology, Volume 2026, Issue 1, 2026.
Introduction Castleman disease is an uncommon benign lymphoproliferative condition that includes diverse clinical, biochemical, and histological variations, each characterized by unique prognoses and therapeutic approaches. The aim of our study was to characterize the clinical and paraclinical features, as well as the management approaches, of ...
Tayssir Ben Achour   +20 more
wiley   +1 more source

Hodgkin Lymphoma and Castleman Disease: When One Blood Disease Can Hide Another

open access: yesCase Reports in Hematology, Volume 2017, Issue 1, 2017., 2017
We describe a rare case of Castleman disease associated de novo with Hodgkin lymphoma. The incidence of Castleman disease is rare; only a few studies have described it in de novo association with Hodgkin lymphoma. The patient described here complained of unique evolutionary axillary adenopathy.
L. Filliatre-Clement   +5 more
wiley   +1 more source

The Evolution and Recent Advances in Diagnostic Criteria for Idiopathic Multicentric Castleman Disease

open access: yesAmerican Journal of Hematology, Volume 100, Issue 11, Page 2064-2073, November 2025.
Idiopathic Multicentric Castleman Disease. ABSTRACT Idiopathic multicentric Castleman disease (iMCD) is a rare cytokine‐driven disorder characterized by systemic inflammation, organ dysfunction, and altered lymph node microscopic architecture. Over the past decade, diagnostic criteria have evolved significantly, integrating clinical, histopathological,
FNU Alnoor   +11 more
wiley   +1 more source

A Rare Coexistence of Retroperitoneal Pararenal Castleman's Disease with Focal Nodular Hyperplasia

open access: yesCase Reports in Surgery, 2013
Castleman's disease is a distinct form of lymph node hyperplasia divided into a solitary and a multicentric type. The solitary type occurs most commonly in the mediastinum and is usually asymptomatic.
Theodosios Theodosopoulos   +6 more
doaj   +1 more source

A Palpable Painless Axillary Mass as the Clinical Manifestation of Castleman’s Disease in a Patient with Hepatitis C Disease

open access: yesCase Reports in Medicine, Volume 2016, Issue 1, 2016., 2016
Introduction. Castleman’s disease (CD) is a rare lymphoproliferative disorder. CD is divided into two clinical subtypes: the most common unicentric and the less usual multicentric subtype. The majority of unicentric CD affects the mediastinum, while neck, abdomen, and axilla are less common locations. Case Presentation.
Athanasia K. Papazafiropoulou   +11 more
wiley   +1 more source

HIV‐negative HHV8‐positive multicentric Castleman's disease coexistent with atypical Kaposi's sarcoma

open access: yesJEADV Clinical Practice, Volume 3, Issue 5, Page 1606-1610, December 2024.
Abstract The co‐occurence of multicentric Castleman's disease (MCD) and Kaposi's sarcoma (KS) represents a rare clinical entity, mostly observed in individuals infected with the human immunodeficiency virus (HIV). Human herpesvirus 8 (HHV‐8) is attributed a crucial etiological role in both conditions. This study presents the case of a 75‐year‐old woman
Anna Scattone   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy